Department of Medicine, Unit of Dermatology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
Acta Derm Venereol. 2013 Jul 6;93(4):411-6. doi: 10.2340/00015555-1517.
Clinical management of primary cutaneous melanomas is based on histopathological staging of the tumour. The aim of this study was to investigate, in a non-selected population in clinical practice, the agreement rate between general pathologists and pathologists experienced in melanoma in terms of the evaluation of histopathological prognostic parameters in cutaneous malignant melanomas, and to what extent the putative variability affected clinical management. A total of 234 cases of invasive cutaneous malignant melanoma were included in the study from the Stockholm-Gotland Healthcare Region in Sweden. Overall interobserver variability between a general pathologist and an expert review was 68.8-84.8%. Approximately 15.5% of melanomas ≤1 mm were re-classified either as melanoma in situ or melanomas >1 mm after review. In conclusion, review by a pathologist experienced in melanoma resulted in a change in recommendations about surgical excision margins and/or sentinel node biopsy in subgroups of T1 melanomas.
原发性皮肤黑色素瘤的临床管理基于肿瘤的组织病理学分期。本研究的目的是在临床实践中的非选择性人群中,调查普通病理学家和黑色素瘤专家在评估皮肤恶性黑色素瘤的组织病理学预后参数方面的一致性,并探讨这种潜在的可变性对临床管理的影响。本研究共纳入了来自瑞典斯德哥尔摩-哥塔兰医疗区的 234 例侵袭性皮肤恶性黑色素瘤病例。普通病理学家和专家之间的整体观察者间变异性为 68.8-84.8%。大约 15.5%的≤1mm 黑色素瘤经重新评估后被归类为原位黑色素瘤或>1mm 的黑色素瘤。总之,由黑色素瘤专家进行审查后,T1 期黑色素瘤的手术切除边缘和/或前哨淋巴结活检的建议发生了变化。